Cargando…

Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)

Non-small-cell lung cancer (NSCLC) causes significant mortality each year. After successful resection of disease stage IB (>4 cm) to IIIA (per AJCC 7), adjuvant platinum-based chemotherapy improves median overall survival and is the standard of care, but many patients still experience recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sands, Jacob M, Mandrekar, Sumithra J, Kozono, David, Oxnard, Geoffrey R, Hillman, Shauna L, Wigle, Dennis A, Govindan, Ramaswamy, Carlisle, Jennifer, Gray, Jhanelle, Salama, Joseph K, Raez, Luis, Ganti, Apar, Foster, Nathan, Malik, Shakun, Bradley, Jeffrey, Kelly, Karen, Ramalingam, Suresh S, Stinchcombe, Thomas E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Clinical Trial Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293026/ https://www.ncbi.nlm.nih.gov/pubmed/33878954 http://dx.doi.org/10.2217/imt-2021-0019

Ejemplares similares

The alchemist
por: Jonson, Ben, 1573?-1637
Publicado: (1966)

Alchemists and toxicants.
por: Goehl, T J
Publicado: (1995)

Sustainable Health Informatics: Health Informaticians as Alchemists
por: NØHR, Christian, et al.
Publicado: (2019)

THE PORTRAIT OF A MEDIEVAL ALCHEMIST WITH SYMBOLS OF ELEMENTS IMITATING CREATION
por: Mahdihassan, S.
Publicado: (1988)

Newton the alchemist: science, enigma, and the quest for nature's secret fire
por: Newman, William
Publicado: (2018)

An unknown Hebrew medical alchemist: a medieval treatise on the quinta essentia.
por: Patai, R
Publicado: (1984)

John Dee and the alchemists: Practising and promoting English alchemy in the Holy Roman Empire
por: Rampling, Jennifer M.
Publicado: (2012)

Wand of the Alchemist: What the Man of Science May Secure from Coal Tar
Publicado: (1898)

Abu Bakr Muhammad Ibn Zakariya Al Razi (Rhazes): Philosopher, Physician and Alchemist
por: Amr, Samir S., et al.
Publicado: (2007)

The road to improving cardiac resynchronization therapy outcomes: Paved with gold or an alchemist’s dead end?
por: Deering, Thomas F., et al.
Publicado: (2022)

Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials
por: Le-Rademacher, Jennifer G., et al.
Publicado: (2020)

Big science: they're the new alchemists of science and their made-in-Canada projects are turning heads around the world
por: Brady, M
Publicado: (2003)

Characteristics of toxicity occurrence patterns in concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced non-small cell lung cancer: a pooled analysis based on individual patient data of CALGB/Alliance trials
por: Yang, Lexie Zidanyue, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Cancer Clinical Trials
por: Boughey, Judy C., et al.
Publicado: (2021)

Genomic advances and their impact on clinical trial design
por: Mandrekar, Sumithra J, et al.
Publicado: (2009)

Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)
por: Yellala, Amulya, et al.
Publicado: (2020)

Cisplatin or carboplatin for advanced non-small cell lung cancer: does it really matter?
por: Kesireddy, Meghana, et al.
Publicado: (2021)

Promising trends in lung cancer care, but are we overlooking the majority?
por: Sharma, Bhavina, et al.
Publicado: (2023)

Clinical Utility of Mobocertinib in the Treatment of NSCLC – Patient Selection and Reported Outcomes
por: Arnold, Abram, et al.
Publicado: (2023)

EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
por: Reade, Chad A, et al.
Publicado: (2009)

The Direct Assignment Option as a Modular Design Component: An Example for the Setting of Two Predefined Subgroups
por: An, Ming-Wen, et al.
Publicado: (2015)

phase1RMD: An R package for repeated measures dose-finding designs with novel toxicity and efficacy endpoints
por: Yin, Jun, et al.
Publicado: (2021)

Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trials
por: Ou, Fang-Shu, et al.
Publicado: (2021)

To Chemo or Not to Chemo… That Is the Question
por: Martin, Maria Felisa Eva B., et al.
Publicado: (2023)

Current concepts in the management of small cell lung cancer
por: Ganti, Apar Kishor, et al.
Publicado: (2013)

Pancytopenia due to iron deficiency worsened by iron infusion: a case report
por: Ganti, Apar Kishor, et al.
Publicado: (2007)

Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma
por: Macha, Muzafar A, et al.
Publicado: (2013)

Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database
por: Anggondowati, Trisari, et al.
Publicado: (2020)

Recurrent Cushing Syndrome Secondary to Metastatic Adrenocortical Carcinoma in a Patient With Previously Resected Adenoma
por: Addasi, Noor, et al.
Publicado: (2021)

Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials
por: Le-Rademacher, Jennifer G., et al.
Publicado: (2019)

Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities
por: Ezzalfani, Monia, et al.
Publicado: (2013)

Manual Washington® de oncología /
por: Govindan, Ramaswamy
Publicado: (2016)

“From chemo to chemo”—the temporal paradox of chemotherapy
por: Moskalewicz, Marcin, et al.
Publicado: (2021)

1,3,5-Triphenylbenzene: a versatile photoluminescent chemo-sensor platform and supramolecular building block
por: Vishnoi, Pratap, et al.
Publicado: (2018)

Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience
por: Zahrieh, David, et al.
Publicado: (2022)

Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials
por: An, Ming-Wen, et al.
Publicado: (2019)

Exertional Chest Pain and Dyspnea From Hyperviscosity Syndrome Related to Marginal Zone Lymphoma
por: Dhakal, Prajwal, et al.
Publicado: (2014)

Chemo Heart
por: DeFilippis, Ersilia M.
Publicado: (2017)

Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
por: Scagliotti, Giorgio, et al.
Publicado: (2010)

Molecular profile of lung cancer in never smokers
por: Subramanian, Janakiraman, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hvag7lq75mfnan8gi96g6ta27c